Evidence map›Paper›PMID 30947712›Full record

ArticleLipids in health and disease2019

Association between skeletal muscle mass and serum concentrations of lipoprotein lipase, GPIHBP1, and hepatic triglyceride lipase in young Japanese men.

Ryutaro Matsumoto, Katsuhiko Tsunekawa, Yoshifumi Shoho, Yoshimaro Yanagawa, Nobuo Kotajima, Shingo Matsumoto, Osamu Araki, Takao Kimura, Katsuyuki Nakajima, Masami Murakami

Open access · goldAbstract read
In one paragraph

Article in Lipids in health and disease, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
2.3field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 21 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Sex Differences of Sarcopenia in an Elderly Asian Population: The Prevalence and Risk Factors.International journal of environmental research and public health · 2022
    Article
  6. Article
  7. Article
  8. Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Ryutaro MatsumotoDepartment of Clinical Laboratory Medicine, Gunma University Graduate School of Medicine, Maebashi, 371-8511, Japan.
Katsuhiko TsunekawaDepartment of Clinical Laboratory Medicine, Gunma University Graduate School of Medicine, Maebashi, 371-8511, Japan. ktsune@gunma-u.ac.jp.ORCID http://orcid.org/0000-0002-6119-4158
Yoshifumi ShohoDepartment of Clinical Laboratory Medicine, Gunma University Graduate School of Medicine, Maebashi, 371-8511, Japan.
Yoshimaro YanagawaDepartment of Clinical Laboratory Medicine, Gunma University Graduate School of Medicine, Maebashi, 371-8511, Japan.
Nobuo KotajimaDepartment of Clinical Laboratory Medicine, Gunma University Graduate School of Medicine, Maebashi, 371-8511, Japan.
Shingo MatsumotoGraduate School of Health and Sport Science, Nippon Sport Science University, Yokohama, 227-0033, Japan.
Osamu ArakiDepartment of Clinical Laboratory Medicine, Gunma University Graduate School of Medicine, Maebashi, 371-8511, Japan.
Takao KimuraDepartment of Clinical Laboratory Medicine, Gunma University Graduate School of Medicine, Maebashi, 371-8511, Japan.
Katsuyuki NakajimaDepartment of Clinical Laboratory Medicine, Gunma University Graduate School of Medicine, Maebashi, 371-8511, Japan.
Masami MurakamiDepartment of Clinical Laboratory Medicine, Gunma University Graduate School of Medicine, Maebashi, 371-8511, Japan.
Gunma University · JPNippon Sport Science University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundTwo important regulators for circulating lipid metabolisms are lipoprotein lipase (LPL) and hepatic triglyceride lipase (HTGL). In relation to this, glycosylphosphatidylinositol anchored high-density lipoprotein binding protein 1 (GPIHBP1) has been shown to have a vital role in LPL lipolytic processing. However, the relationships between skeletal muscle mass and lipid metabolism, including LPL, GPIHBP1, and HTGL, remain to be elucidated. Demonstration of these relationships may lead to clarification of the metabolic dysfunctions caused by sarcopenia. In this study, these relationships were investigated in young Japanese men who had no age-related factors; participants included wrestling athletes with abundant skeletal muscle.

methodsA total of 111 young Japanese men who were not taking medications were enrolled; 70 wrestling athletes and 41 control students were included. The participants' body compositions, serum concentrations of lipoprotein, LPL, GPIHBP1 and HTGL and thyroid function test results were determined under conditions of no extreme dietary restrictions and exercises.

resultsCompared with the control participants, wrestling athletes had significantly higher skeletal muscle index (SMI) (p < 0.001), higher serum concentrations of LPL (p < 0.001) and GPIHBP1 (p < 0.001), and lower fat mass index (p = 0.024). Kruskal-Wallis tests with Bonferroni multiple comparison tests showed that serum LPL and GPIHBP1 concentrations were significantly higher in the participants with higher SMI. Spearman's correlation analyses showed that SMI was positively correlated with LPL (ρ = 0.341, p < 0.001) and GPIHBP1 (ρ = 0.309, p = 0.001) concentration. The serum concentrations of LPL and GPIHBP1 were also inversely correlated with serum concentrations of triglyceride (LPL, ρ = - 0.198, p = 0.037; GPIHBP1, ρ = - 0.249, p = 0.008). Serum HTGL concentration was positively correlated with serum concentrations of total cholesterol (ρ = 0.308, p = 0.001), low-density lipoprotein-cholesterol (ρ = 0.336, p < 0.001), and free 3,5,3'-triiodothyronine (ρ = 0.260, p = 0.006), but not with SMI.

conclusionsThe results suggest that increased skeletal muscle mass leads to improvements in energy metabolism by promoting triglyceride-rich lipoprotein hydrolysis through the increase in circulating LPL and GPIHBP1.

Indexed as

AdolescentAdultAthletesCholesterol, LDLEnergy MetabolismExerciseFemaleGenetic Association StudiesHumansLipaseLipid MetabolismLipoprotein LipaseLiverMaleMuscle, SkeletalMuscular DiseasesCholesterol, LDLGPIHBP1 protein, humanLipaseLipoprotein LipaseReceptors, LipoproteinTriglyceridesGlycosylphosphatidylinositol anchored high-density lipoprotein binding protein 1 (GPIHBP1)Hepatic triglyceride lipase (HTGL)Lipoprotein lipase (LPL)Skeletal muscle massThyroid hormone

Identifiers

PMID30947712
PMCPMC6449999
OpenAlexW2946185697

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.